B. Riley Wealth Advisors Inc. decreased its stake in Morgan Stanley (NYSE:MS - Free Report) by 11.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 26,607 shares of the financial services provider's stock after selling 3,467 shares during the period. B. Riley Wealth Advisors Inc.'s holdings in Morgan Stanley were worth $3,345,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently modified their holdings of MS. Norges Bank purchased a new stake in shares of Morgan Stanley in the fourth quarter worth about $1,910,200,000. Capital Research Global Investors lifted its stake in shares of Morgan Stanley by 44.8% in the fourth quarter. Capital Research Global Investors now owns 21,794,873 shares of the financial services provider's stock worth $2,740,051,000 after acquiring an additional 6,744,333 shares in the last quarter. FMR LLC lifted its stake in shares of Morgan Stanley by 11.9% in the fourth quarter. FMR LLC now owns 25,561,560 shares of the financial services provider's stock worth $3,213,599,000 after acquiring an additional 2,725,335 shares in the last quarter. Raymond James Financial Inc. acquired a new position in shares of Morgan Stanley in the fourth quarter worth about $324,118,000. Finally, Schroder Investment Management Group lifted its stake in shares of Morgan Stanley by 50.8% in the fourth quarter. Schroder Investment Management Group now owns 7,282,156 shares of the financial services provider's stock worth $915,731,000 after acquiring an additional 2,453,470 shares in the last quarter. Hedge funds and other institutional investors own 84.19% of the company's stock.
Morgan Stanley Price Performance
Shares of NYSE:MS traded down $0.29 on Friday, reaching $127.87. 6,434,557 shares of the company traded hands, compared to its average volume of 6,706,065. Morgan Stanley has a fifty-two week low of $90.94 and a fifty-two week high of $142.03. The company's 50 day moving average is $117.49 and its 200-day moving average is $125.36. The stock has a market capitalization of $205.14 billion, a PE ratio of 16.10, a P/E/G ratio of 1.18 and a beta of 1.30. The company has a debt-to-equity ratio of 3.14, a current ratio of 0.80 and a quick ratio of 0.80.
Morgan Stanley (NYSE:MS - Get Free Report) last announced its quarterly earnings data on Friday, April 11th. The financial services provider reported $2.60 EPS for the quarter, beating analysts' consensus estimates of $2.21 by $0.39. Morgan Stanley had a return on equity of 14.39% and a net margin of 12.48%. The company had revenue of $17.74 billion during the quarter, compared to the consensus estimate of $16.81 billion. During the same quarter in the prior year, the firm earned $2.02 EPS. The company's quarterly revenue was up 17.2% compared to the same quarter last year. As a group, analysts anticipate that Morgan Stanley will post 8.56 earnings per share for the current fiscal year.
Morgan Stanley Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Wednesday, April 30th were issued a $0.925 dividend. The ex-dividend date was Wednesday, April 30th. This represents a $3.70 dividend on an annualized basis and a dividend yield of 2.89%. Morgan Stanley's payout ratio is currently 43.43%.
Insider Activity
In other news, Director Robert H. Herz sold 800 shares of the stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $119.32, for a total value of $95,456.00. Following the completion of the sale, the director now owns 96,760 shares in the company, valued at $11,545,403.20. This represents a 0.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Andrew M. Saperstein sold 40,000 shares of the stock in a transaction on Friday, May 2nd. The shares were sold at an average price of $120.00, for a total value of $4,800,000.00. Following the completion of the sale, the insider now owns 335,765 shares of the company's stock, valued at $40,291,800. The trade was a 10.64% decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,868 shares of company stock worth $6,019,548 over the last quarter. Corporate insiders own 0.19% of the company's stock.
Analyst Upgrades and Downgrades
Several research analysts recently commented on the company. JMP Securities reiterated a "market perform" rating on shares of Morgan Stanley in a research note on Monday, April 14th. Bank of America cut their price objective on Morgan Stanley from $150.00 to $144.00 and set a "buy" rating on the stock in a research note on Wednesday, April 2nd. Citigroup cut their price objective on Morgan Stanley from $135.00 to $125.00 and set a "neutral" rating on the stock in a research note on Monday, March 24th. Erste Group Bank raised Morgan Stanley from a "hold" rating to a "strong-buy" rating in a report on Saturday, May 24th. Finally, Wells Fargo & Company lowered their target price on Morgan Stanley from $130.00 to $120.00 and set an "equal weight" rating for the company in a report on Monday, April 14th. Eleven investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $132.46.
View Our Latest Report on MS
Morgan Stanley Profile
(
Free Report)
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Featured Stories

Before you consider Morgan Stanley, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Morgan Stanley wasn't on the list.
While Morgan Stanley currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report